FROST PHILLIP MD ET AL 4
4 · Cocrystal Pharma, Inc. · Filed Dec 31, 2025
Insider Transaction Report
Form 4
FROST PHILLIP MD ET AL
Director10% Owner
Transactions
- Purchase
Common Stock
2025-12-30$0.97/sh+20,000$19,310→ 1,788,551 total(indirect: By Trust)
Holdings
- 27,100
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions ranging from $0.9635 to $0.9700, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the preceding sentence.
- [F2]These shares are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole stockholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is the sole stockholder of Frost-Nevada Corporation. The Reporting Person disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]Includes shares of common stock issuable upon vesting of restricted stock units.